Propofol relieves inflammation in MIRI rats by inhibiting Rho/Rock signaling pathway

C Liu1, Y Li

  • 1Department of Anesthesiology, Affiliated Hospital of Chengde Medical College, Chengde, China. liyan0567@126.com.

Abstract

Insights

Propofol effectively mitigates myocardial ischemia-reperfusion injury (MIRI) in rats by reducing inflammation and cell apoptosis. This protective effect is achieved by inhibiting the Rho/Rock signaling pathway, offering a potential therapeutic strategy.

Area of Science:

  • Cardiology
  • Pharmacology
  • Molecular Biology

Background:

  • Myocardial ischemia-reperfusion injury (MIRI) is a significant clinical challenge.
  • Understanding the molecular mechanisms underlying MIRI is crucial for developing effective treatments.

Purpose of the Study:

  • To investigate the protective effects of propofol against MIRI in a rat model.
  • To elucidate the underlying mechanism involving the Rho/Rock signaling pathway.

Main Methods:

  • Established MIRI models in Sprague-Dawley rats.
  • Administered propofol to a treatment group.
  • Measured serum biomarkers (LDH, CK-MB, IL-6, IL-10, TNF-α).
  • Assessed myocardial cell apoptosis using TUNEL assay.
  • Quantified RhoA and Rock2 expression via qRT-PCR and Western blotting.

Main Results:

  • Propofol significantly reduced serum LDH and CK-MB levels.
  • Propofol decreased pro-inflammatory cytokines (IL-6, TNF-α) and increased anti-inflammatory cytokine (IL-10).
  • Propofol markedly reduced myocardial cell apoptosis.
  • Propofol downregulated the expression of RhoA and Rock2.

Conclusions:

  • Propofol demonstrates significant cardioprotective effects against MIRI.
  • Propofol alleviates inflammation and oxidative stress.
  • The protective mechanism involves the inhibition of the Rho/Rock signaling pathway, reducing myocardial cell apoptosis.

Related Concept Videos